advertisement
Bock F 4
Showing records 1 to 4 | Display only abstracts from Bock F in IGR 15-2107738 The novel role of lymphatic vessels in the pathogenesis of ocular diseases
Clahsen T; Hadrian K; Notara M; Schlereth SL; Howaldt A; Prokosch V; Volatier T; Hos D; Schroedl F; Kaser-Eichberger A; Heindl LM; Steven P; Bosch JJ; Steinkasserer A; Rokohl AC; Rokohl AC; Liu H; Mestanoglu M; Kashkar H; Schumacher B; Kiefer F; Schulte-Merker S; Schulte-Merker S; Matthaei M; Hou Y; Fassbender S; Jantsch J; Zhang W; Enders P; Bachmann B; Bock F; Cursiefen C
Progress in Retinal and Eye Research 2023; 0: 101157 (IGR: 23-4)
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Lorenz K; Scheller Y; Bell K; Grus F; Ponto KA; Bock F; Cursiefen C; Flach J; Gehring M; Peto T; Silva R; Tal Y; Pfeiffer N
Trials 2017; 18: 128 (IGR: 18-4)
53627 Short- and long-term corneal vascular effects of tafluprost eye drops
Hos D; Koch KR; Bock F; Grajewski RS; Dietlein TS; Cursiefen C; Heindl LM
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 1919-1927 (IGR: 15-2)
19328 Inhibition of angiogenesis in the anterior chamber of the eye
Bock F; Konig Y; Dietrich T; Zimmermann P; Baier M; Cursiefen C
Ophthalmologe 2007; 104: 336-344 (IGR: 9-3)
